1 domain / 2 areas / 2 specializations
Charles River Associates
Data updated
Economic and strategy consultancy with life sciences advisory services, including published analysis on the evolving psychedelic therapeutics landscape and market implications.
Consultancy & Advisory Snapshot
Commercial Strategy ConsultingGeography
Global
Coverage
Global
Psychedelic Focus
Psychedelic-Adjacent Focus
Engagement
Active
Pipeline Stage Coverage
Client Types
Consultancy Notes
Charles River Associates is an international economics and strategy consultancy founded in 1965, with a life sciences practice serving pharmaceutical companies, law firms and regulators on commercial strategy, pricing, market access and litigation matters. Its documented psychedelic work is analytical rather than client-disclosed, notably the CRA Insights publication on psychedelic therapies covering the late-stage pipeline, regulatory setbacks and go-to-market strategy. It should not be confused with Charles River Laboratories, a separate preclinical CRO.
Documented Engagements
CRA Insights publication on psychedelic therapies
Jul 1, 2025
Landscape analysis of the psychedelic therapeutics pipeline, regulatory environment and commercialisation strategy published in CRA's Life Sciences Insights series.
Psychedelic therapies: Navigating setbacks and opportunities in a transforming landscapeSource Evidence
Charles River Associates (official website)
https://www.crai.com/
Life Sciences | Charles River Associates
https://www.crai.com/industries/life-sciences/
Psychedelic therapies: Navigating setbacks and opportunities in a transforming landscape (CRA Insights PDF)
https://media.crai.com/wp-content/uploads/2025/07/09154605/LS-Insights-Psychedelic-therapies-Navigating-setbacks-and-opportunities-in-a-transforming-landscape.pdf
Quick Facts
- Type
- Other
- Website
- Visit